Not applicableNo Longer AvailableNCT00495066What this trial is testingCompassionate Use Trial for Unresectable Melanoma With IpilimumabWho this might be right forMelanoma Bristol-Myers Squibb
Testing effectiveness (Phase 2)Active Not RecruitingNCT03235245What this trial is testingImmunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and BinimetinibWho this might be right forUnresectable Stage III MelanomaStage IV Melanoma European Organisation for Research and Treatment of Cancer - EORTC 271
Testing effectiveness (Phase 2)Study completedNCT04068181What this trial is testingTalimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy (MASTERKEY-115) (Mk-3475-A07/KEYNOTE-A07).Who this might be right forMelanoma Amgen 72
Testing effectiveness (Phase 2)Ended earlyNCT00961376What this trial is testingVaccination of Melanoma Patients With Total or CD25-depleted Peripheral Blood Mononuclear Cell (PBMC)Who this might be right forMelanoma Providence Health & Services 5
Testing effectiveness (Phase 2)Study completedNCT00003989What this trial is testingISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic MelanomaWho this might be right forLung CancerMelanoma (Skin) European Organisation for Research and Treatment of Cancer - EORTC 50
Early research (Phase 1)Ended earlyNCT02200562What this trial is testingIpilimumab and Dabrafenib in the 1st Line Tx of Unresectable Stage III/IV MelanomaWho this might be right forStage III or IV Melanoma University of Utah 6
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Early research (Phase 1)Study completedNCT02141542What this trial is testingPhase I Clinical Trial of Tremelimumab Plus MEDI3617 in Patients With Unresectable Stage III or Stage IV MelanomaWho this might be right forMetastatic Melanoma F. Stephen Hodi, MD 15
Early research (Phase 1)Ended earlyNCT01519323What this trial is testingBRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 MutationsWho this might be right forMalignant Melanoma Hoffmann-La Roche 6
Testing effectiveness (Phase 2)Study completedNCT02304458What this trial is testingNivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or SarcomasWho this might be right forMetastatic MelanomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Hodgkin Lymphoma+20 more National Cancer Institute (NCI) 140
Testing effectiveness (Phase 2)Study completedNCT02392871What this trial is testingRadiotherapy & Combi in Metastatic MelanomaWho this might be right forMetastatic Melanoma Melanoma and Skin Cancer Trials Limited 10
Testing effectiveness (Phase 2)Looking for participantsNCT01638676What this trial is testingA Phase I/II Trial of Vemurafenib and Metformin to Melanoma PatientsWho this might be right forMelanoma University of Louisville 55
Testing effectiveness (Phase 2)Looking for participantsNCT05136196What this trial is testingBiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT04200040What this trial is testingA Clinical Study to Evaluate the Safety and Efficacy of OrienX010 in Unresectable Malignant Melanoma PatientsWho this might be right forMelanoma (Skin) OrienGene Biotechnology Ltd. 165
Testing effectiveness (Phase 2)UnknownNCT01168050What this trial is testingEfficacy of Nilotinib in First or Second Line Treatment of Primary Melanomas Stage III Unresectable Melanomas.Who this might be right forMalignant Skin Melanoma T0Stage III MelanomaStage IV Melanoma+1 more Assistance Publique - Hôpitaux de Paris 25
Early research (Phase 1)Looking for participantsNCT04913285What this trial is testingEvaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid TumorsWho this might be right forSolid Tumor, AdultNon-small Cell Lung CancerMelanoma Pierre Fabre Medicament 400
Early research (Phase 1)Study completedNCT03159117What this trial is testingPfizer PF-06688992 in Patients With Stage III or Stage IV MelanomaWho this might be right forMelanoma Memorial Sloan Kettering Cancer Center 7
Early research (Phase 1)Study completedNCT02983006What this trial is testingStudy of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV MelanomaWho this might be right forMelanoma NYU Langone Health 12
Large-scale testing (Phase 3)Ended earlyNCT02967692What this trial is testingThe Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced MelanomaWho this might be right forMelanoma Novartis Pharmaceuticals 568
Early research (Phase 1)Study completedNCT01066390What this trial is testingA Study on the Safety and Immunogenicity of Combined Intradermal and Intravenous Administration of an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Previously Treated Unresectable Stage III or IV MelanomaWho this might be right forMelanoma Bart Neyns 18